🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The main purpose of this study is to determine effect of orforglipron capsu...
Status
Completed
Location
Fortrea Clinical Research Unit Inc.
Start Date
2024-01-02
Trial ID
NCT06186622
Treatments Being Tested
The aim of the study is to gather information on how the drug behaves in he...
Status
Completed
Location
GSK Investigational Site
Start Date
2025-07-07
Trial ID
NCT07066722
This is a single-center, non-randomized, open-label, self-controlled, Phase...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-05-11
Trial ID
NCT07565441
This study aims to evaluate the impact of strong CYP3A4 induction on the ph...
Status
Completed
Location
Crinetics Study Site
Start Date
2026-05-28
Trial ID
NCT07570082
Treatments Being Tested
This study consisted of 2 parts: Part 1 and 2. The purpose of this study wa...
Status
Completed
Location
Nuvisan GmbH
Start Date
2021-10-04
Trial ID
NCT05064488
Treatments Being Tested
This is a Phase 1 study to evaluate the potential drug-drug interaction (DD...
Status
Withdrawn
Location
Gabrail Cancer Research Center
Start Date
2024-11-15
Trial ID
NCT05828303
Treatments Being Tested
This is a Phase 1, open-label, 3-period study to determine radiprodil's pot...
Status
Completed
Location
Nucleus Network Melbourne
Start Date
2025-05-20
Trial ID
NCT06975605
Treatments Being Tested
The study followed an open-label, randomized, single-dose (0.25mg), four-pe...
Status
Completed
Location
Xiangya Hospital Central South University
Start Date
2020-07-05
Trial ID
NCT06546215
Treatments Being Tested
This study will assess safety, tolerability and pharmacokinetic (PK) of VH3...
Status
Withdrawn
Location
GSK Investigational Site
Start Date
2024-08-02
Trial ID
NCT06533280